Syzygium siamense

Syzygium siamense · Accepted scientific name

Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆

Syzygium siamense is a distinctive botanical species recognized for its unique biological properties and medicinal potential. Scientific investigations have specifically focused on the chemical composition found within its fleshy fruits. These fruit preparations have demonstrated significant biological activity during various pharmacological assays. Notably, research has highlighted the cytotoxic effects exhibited by these extracts against certain cell lines. Understanding these properties offers valuable insights into the therapeutic possibilities of this plant.

Quick facts
Synonyms
Eugenia Rubida · Eugenia Siamensis · 3 more
Common names
Not available
Family
Myrtaceae
Distribution
Not available
Plant Parts
Fruit

Classification

Common Names

Syzygium siamense is a distinctive plant species known by several different regional names. In some contexts, it is commonly referred to as czapetka syjamska. It also carries the local Thai name ชมพู่น้ำ, reflecting its cultural significance in the region. These various identifiers highlight the diverse linguistic connections associated with the species. Understanding these common names helps enthusiasts and botanists identify the plant across different locations.

Sources: Catalogue of Life (COL)

Synonyms

Syzygium siamense is a plant species known for its complex taxonomic history and various botanical synonyms. Researchers have historically identified this plant under several different names, including Eugenia jambos var. sylvatica and Eugenia javanica var. balansae. It has also been documented in literature as Eugenia rubida and Eugenia siamensis. Furthermore, the name Syzygium jambos var. sylvaticum has been applied to the same specimen in previous studies. Navigating these overlapping classifications is essential for anyone studying the botanical relationships of this species.

Sources: The World Checklist of Vascular Plants (WCVP)

Taxonomy

Syzygium siamense is a distinctive species that belongs to the vast kingdom Plantae. Within this kingdom, it is classified under the class Equisetopsida. This plant is further categorized into the order Myrtales, which helps define its biological structure. It belongs to the specific genus Syzygium, a group known for its diverse botanical characteristics. Finally, its placement within the family Myrtaceae highlights its evolutionary connection to other well-known flowering plants.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Myrtales
Family Myrtaceae
Genus Syzygium

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Syzygium siamense is a distinctive plant species primarily found throughout the tropical regions of Asia. Its natural distribution is concentrated within the Indo-China peninsula, where it flourishes in diverse local environments. Specifically, this species can be located across the varied landscapes of Cambodia, Laos, and Myanmar. It is also commonly documented growing within the borders of Thailand and Vietnam. Together, these interconnected territories form the core geographical range for this important tropical plant.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Syzygium siamense is a self-supporting plant that exhibits a distinct tree growth form. This species typically reaches a maximum height of approximately 15 meters in the wild. Its robust structure allows it to stand firmly as a significant feature within its natural ecosystem.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Syzygium siamense has demonstrated significant biological potential through the isolation of various sterol compounds from its fruits. Research has identified a new sterol, stigmast-5-ene-3beta,17alpha-diol, alongside six other known chemical constituents. These isolated compounds were specifically evaluated for their ability to inhibit the growth of malignant cells. The study revealed that these substances possess notable cytotoxic activities against human oral epidermoid carcinoma, breast cancer, and small cell lung cancer cell lines. Such findings highlight the importance of investigating this plant species for potential therapeutic applications in oncology.

Compounds

Conditions

Syzygium siamense contains various steroids isolated from its fruits that demonstrate significant cytotoxic activities. These compounds exhibit the ability to treat human breast cancer (BC) cell lines. Furthermore, the plant shows effectiveness against human oral epidermoid carcinoma cancer (KB). It also provides therapeutic potential for addressing human small cell lung cancer (NCI-H187). Through these various interactions, the plant proves to be a source of potent anticancer agents.

Preparations

Syzygium siamense is prepared as fruits for the extraction of various chemical compounds. Researchers isolated several sterols from these fruits, including a newly identified stigmast-5-ene-3beta,17alpha-diol. The fruit-derived substances also include stigmast-5-ene-3beta-yl formate, which was reported for the first time from a natural source. These specific components obtained from the fruit were subsequently tested for their potential medicinal properties. Ultimately, the compounds derived from the Syzygium siamense fruits demonstrated cytotoxic activities against several human cancer cell lines.

Parts used

Syzygium siamense contains specific biological components that are of significant interest to pharmacological research. Scientists have focused their attention on the plant's fruit to isolate various chemical compounds. Recent studies have successfully identified several cytotoxic steroids, including a newly reported stigmast-5-ene-3beta-yl formate, from these fruit extracts. Through spectroscopic methods, researchers were able to elucidate the complex structures of these isolated sterols. These findings are particularly important because the compounds demonstrated measurable cytotoxic activity against several human cancer cell lines.